George Church has been a pioneer in developing revolutionary technologies that gave birth to the field of modern human genomics. In 1984, George developed the first direct genomic sequencing technology and helped launch the Human Genome Project. He invented the broadly applied concepts of molecular multiplexing and tags, homologous recombination methods, and array of DNA synthesizers. He is also a co-inventor of NextGen DNA sequencing technology. George is professor of genetics at Harvard Medical School and professor of health sciences and technology at Harvard and MIT. George received BA degrees in zoology and chemistry from Duke University and his PhD in genetics from Harvard.
Robert Green is a medical geneticist and physician-scientist focused on the medical, behavioral, and economic outcomes of genomic medicine. Dr. Green directs the G2P Research Program at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School. He led the first experimental trials disclosing common complex disease risk (REVEAL Study) and one of the first prospective studies of direct-to- consumer genetic testing services (PGen Study). He currently leads and co-leads the first randomized trials to explore the implementation of medical sequencing in adults and newborns (MedSeq and BabySeq). In 2014, he won the Coriell Prize for Scientific Achievement in Personalized Medicine. A graduate of Amherst College and the University of Virginia School of Medicine, Dr. Green earned a Masters of Public Health in epidemiology from Emory University School of Public Health.
As a computational biologist, Aviv understands the complexities of the human body. Aviv's research focuses on how complex molecular networks function and evolve in the face of genetic and environmental changes over time. She is an associate professor of biology at the Massachusetts Institute of Technology and core member of the Broad Institute of MIT and Harvard University. Aviv is a recipient of the NIH Director’s Pioneer Award, a Sloan fellowship from the Sloan Foundation, and the Overton Prize from the International Society for Computational Biology. She earned her MSc and PhD from Tel Aviv University.
Jay Shendure is revolutionizing medical genetics with the development of new approaches to sequencing and interpreting genetic information. Jay is a professor at the University of Washington School of Medicine and co-inventor of NextGen DNA sequencing technology. The Shendure Lab uses DNA sequencing to uncover the molecular causes of ultra-rare diseases. In 2012 Jay received the prestigious Curt Stern Award from the American Society of Human Genetics (ASHG) for outstanding scientific achievement. He earned his AB in molecular biology from Princeton, his PhD in genetics from Harvard, and his MD from Harvard Medical School.
A professor in the Division of Genetics at Harvard Medical School, Shamil pursues breakthrough research on the evolution of proteins and the contribution of genetic variation to complex diseases. He runs the Sunyaev Lab at the Biomedical Research Institute at Brigham and Women’s Hospital in Boston, where he applies bioinformatics approaches to problems of evolutionary genetics and human population genetics. Shamil has a PhD in Biophysics from the Moscow Institute of Physics and Technology. He received the International HDL Research Award by Pfizer and the John and Virginia Taplin Award from the Harvard-MIT Division of Health Sciences and Technology.
Alan Copperman is the Director of the Division of Reproductive Endocrinology and Infertility as well as the Vice-Chairman of the Department of Obstetrics, Gynecology, and Reproductive Science at Mount Sinai Medical Center. He is a Clinical Professor of Obstetrics, Gynecology, and Reproductive Science at the Mount Sinai School of Medicine and serves as co-director of RMA New York. Alan is a distinguished clinician who has published numerous award-winning papers on egg freezing, infertility, and in vitro fertilization. He received his undergraduate degree from the University of Pennsylvania and his medical degree from New York Medical College. He completed residency in OB/GYN at Yale-New Haven Hospital and continued his training at Mount Sinai as the Martin J. Clyman Fellow in Reproductive Endocrinology. Alan has received annual recognition from New York Magazine, Castle Connolly, and SuperDocs as one of the country’s top fertility doctors.
George Diaz has dedicated his career to solving the mysteries of inherited disease and serving young patients with a wide range of genetic conditions. He is board certified in both Clinical Genetics and Pediatrics and is an Associate Professor in Genetics and Genomic Sciences and Pediatrics at Mount Sinai Hospital in New York City. The Diaz Laboratory is at the cutting-edge of understanding the molecular basis of inherited disease, with a focus on single-gene disorders. The Lab is committed to translational genomics, applying laboratory discoveries to clinical use. George trained at the Health Science Center at the State University of New York (SUNY) and did his Residency and Fellowship at Mt. Sinai Hospital.
Steven Lipkin is advancing the world’s understanding of the links between genes and disease. He is a board certified Medical Geneticist specializing in genetic testing for gastrointestinal diseases. He authored MAPP-MMR, a bioinformatic program used to interpret whether Lynch syndrome missense variants are deleterious mutations or benign polymorphisms. Steve practices at Weill Medical College of Cornell University and New York-Presbyterian Hospital. He trained in Internal Medicine at Duke University and Medical Genetics at the National Human Genome Research Institute.
Gholson Lyon directs the Lyon Lab at Cold Spring Harbor Laboratory, where he focuses on analyzing human genetic variation and its role in severe neuropsychiatric disorders. He is director of Neuropsychiatric Genetics for the Utah Foundation for Biomedical Research, and he is particularly interested in the genetic and pathophysiological basis of neuropsychiatric disorders. Board certified as a Child and Adolescent Psychiatrist, he has an MD from Weill Cornell Medical College, a PhD in pharmacology from Rockefeller University, and a Masters of Philosophy in genetics from the University of Cambridge.
Aaron Spitz is an expert in reproductive medicine. An Assistant Clinical Professor of Urology at the University of California Irvine, he is actively engaged in clinical research and directs the Center for Male Reproductive Medicine and Surgery. In addition, Aaron works closely with in-vitro fertility centers throughout the U.S. to help provide state-of-the-art reproductive care. He earned his medical degree from Cornell University Medical College, completed his urology residency at the University of Southern California Medical Center, and completed a fellowship in male reproductive medicine and surgery at The Baylor College of Medicine in Houston, TX. Aaron has been recognized for excellence in medicine throughout his career, including election into the prestigious Alpha Omega Alpha Honor Medical Society.